Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

Source:http://linkedlifedata.com/resource/pubmed/id/21305523

Download in:

View as

General Info

PMID
21305523